LUND, Sweden, June 9, 2023 /PRNewswire/ — Immunovia AB (Nasdaq: IMMNOV) announces today that Jeff Borcherding, CEO of Immunovia, has purchased 350 000 shares for approximately 670 KSEK. His total holding now amounts to 350 000 shares and 100 000 warrants in Immunovia. About Immunovia…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.